Drug points: Hepatotoxicity associated with zolpidem treatment
1999; BMJ; Volume: 318; Issue: 7192 Linguagem: Inglês
10.1136/bmj.318.7192.1179
ISSN0959-8138
AutoresDavid Karsenti, P Blanc, Yannick Bacq, E H Metman,
Tópico(s)Pharmacological Effects and Toxicity Studies
ResumoZolpidem is a hypnotic drug of the imidazopyridine group. Another imidazopyridine, alpidem, has been withdrawn from the market because of its hepatotoxicity. 1 2 Hepatoxicity has been suspected in association with zolpidem, but it has not been clearly established because of concomitant drug treatment. 3 4 We report a case of acute hepatitis mimicking biliary lithiasis after treatment with zolpidem alone at a therapeutic dose, with reappearance of the hepatoxicity after the drug was reintroduced. A 53 year old woman was admitted in June 1997 for investigation of recurrent abdominal pain. She had no history of recent …
Referência(s)